ツムラの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/09/05 | 3,175 | 3,245 | 3,165 | 3,195 | +30 | +0.9% | 181,800 |
| 2022/09/02 | 3,160 | 3,175 | 3,135 | 3,165 | +20 | +0.6% | 137,900 |
| 2022/09/01 | 3,165 | 3,180 | 3,135 | 3,145 | -50 | -1.6% | 114,900 |
| 2022/08/31 | 3,120 | 3,195 | 3,120 | 3,195 | +40 | +1.3% | 168,000 |
| 2022/08/30 | 3,195 | 3,195 | 3,130 | 3,155 | +10 | +0.3% | 67,400 |
| 2022/08/29 | 3,130 | 3,150 | 3,115 | 3,145 | -55 | -1.7% | 80,100 |
| 2022/08/26 | 3,180 | 3,215 | 3,175 | 3,200 | -15 | -0.5% | 107,800 |
| 2022/08/25 | 3,205 | 3,225 | 3,195 | 3,215 | -10 | -0.3% | 131,500 |
| 2022/08/24 | 3,225 | 3,235 | 3,210 | 3,225 | -25 | -0.8% | 76,100 |
| 2022/08/23 | 3,230 | 3,260 | 3,210 | 3,250 | -40 | -1.2% | 91,600 |
| 2022/08/22 | 3,210 | 3,295 | 3,210 | 3,290 | +75 | +2.3% | 80,400 |
| 2022/08/19 | 3,255 | 3,280 | 3,210 | 3,215 | -60 | -1.8% | 159,800 |
| 2022/08/18 | 3,270 | 3,290 | 3,250 | 3,275 | +15 | +0.5% | 125,400 |
| 2022/08/17 | 3,250 | 3,290 | 3,240 | 3,260 | +50 | +1.6% | 168,900 |
| 2022/08/16 | 3,170 | 3,220 | 3,155 | 3,210 | +10 | +0.3% | 100,200 |
| 2022/08/15 | 3,160 | 3,200 | 3,150 | 3,200 | +20 | +0.6% | 74,500 |
| 2022/08/12 | 3,115 | 3,200 | 3,100 | 3,180 | +75 | +2.4% | 157,100 |
| 2022/08/10 | 3,060 | 3,105 | 3,050 | 3,105 | +35 | +1.1% | 117,000 |
| 2022/08/09 | 3,105 | 3,115 | 3,060 | 3,070 | -30 | -1% | 90,700 |
| 2022/08/08 | 3,100 | 3,115 | 3,070 | 3,100 | -25 | -0.8% | 89,100 |
| 2022/08/05 | 3,055 | 3,125 | 3,055 | 3,125 | +5 | +0.2% | 94,000 |
| 2022/08/04 | 3,130 | 3,140 | 3,050 | 3,120 | +100 | +3.3% | 259,100 |
| 2022/08/03 | 3,100 | 3,100 | 3,015 | 3,020 | -50 | -1.6% | 104,600 |
| 2022/08/02 | 3,155 | 3,160 | 3,070 | 3,070 | -100 | -3.2% | 119,000 |
| 2022/08/01 | 3,120 | 3,175 | 3,110 | 3,170 | +55 | +1.8% | 75,300 |
| 2022/07/29 | 3,205 | 3,205 | 3,110 | 3,115 | -90 | -2.8% | 113,300 |
| 2022/07/28 | 3,190 | 3,220 | 3,180 | 3,205 | +15 | +0.5% | 90,000 |
| 2022/07/27 | 3,180 | 3,205 | 3,180 | 3,190 | -15 | -0.5% | 64,000 |
| 2022/07/26 | 3,250 | 3,250 | 3,205 | 3,205 | -30 | -0.9% | 56,000 |
| 2022/07/25 | 3,245 | 3,250 | 3,220 | 3,235 | -15 | -0.5% | 71,500 |
| 2022/07/22 | 3,230 | 3,275 | 3,220 | 3,250 | +20 | +0.6% | 89,100 |
| 2022/07/21 | 3,165 | 3,240 | 3,165 | 3,230 | +30 | +0.9% | 77,000 |
| 2022/07/20 | 3,175 | 3,200 | 3,140 | 3,200 | +55 | +1.7% | 90,400 |
| 2022/07/19 | 3,180 | 3,180 | 3,115 | 3,145 | -55 | -1.7% | 65,500 |
| 2022/07/15 | 3,210 | 3,220 | 3,170 | 3,200 | -5 | -0.2% | 58,900 |
| 2022/07/14 | 3,200 | 3,220 | 3,170 | 3,205 | +15 | +0.5% | 64,500 |
| 2022/07/13 | 3,220 | 3,225 | 3,180 | 3,190 | -10 | -0.3% | 88,100 |
| 2022/07/12 | 3,215 | 3,220 | 3,165 | 3,200 | -20 | -0.6% | 100,400 |
| 2022/07/11 | 3,205 | 3,225 | 3,190 | 3,220 | +60 | +1.9% | 122,800 |
| 2022/07/08 | 3,150 | 3,195 | 3,090 | 3,160 | +5 | +0.2% | 127,300 |
| 2022/07/07 | 3,165 | 3,170 | 3,135 | 3,155 | +50 | +1.6% | 118,400 |
| 2022/07/06 | 3,085 | 3,115 | 3,080 | 3,105 | ±0 | ±0% | 87,100 |
| 2022/07/05 | 3,115 | 3,120 | 3,085 | 3,105 | -15 | -0.5% | 98,300 |
| 2022/07/04 | 3,100 | 3,130 | 3,085 | 3,120 | +70 | +2.3% | 139,400 |
| 2022/07/01 | 3,060 | 3,130 | 3,035 | 3,050 | +5 | +0.2% | 158,900 |
| 2022/06/30 | 3,065 | 3,095 | 3,030 | 3,045 | +5 | +0.2% | 171,700 |
| 2022/06/29 | 3,010 | 3,050 | 2,990 | 3,040 | +20 | +0.7% | 148,600 |
| 2022/06/28 | 2,977 | 3,020 | 2,967 | 3,020 | +46 | +1.5% | 118,700 |
| 2022/06/27 | 3,000 | 3,010 | 2,955 | 2,974 | -14 | -0.5% | 139,700 |
| 2022/06/24 | 2,994 | 2,999 | 2,972 | 2,988 | +18 | +0.6% | 101,400 |
651～
700
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ツムラ | 430,100円 | +20.9% | +87.3% | 3.16% | 9.61倍 | 1.11倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 久光薬 | 443,700円 | +5.8% | +1.2% | 2.70% | 14.72倍 | 1.17倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| 住友ファーマ | 94,100円 | +26.8% | - | 0.00% | 15.84倍 | 3.27倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ペプチド | 201,800円 | +5.0% | +1.5% | 0.00% | 17.33倍 | 4.61倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 日本新薬 | 373,500円 | +7.9% | +8.9% | 3.32% | 7.99倍 | 1.07倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム
